Matches in Wikidata for { <http://www.wikidata.org/entity/Q64719922> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64719922 description "clinical trial" @default.
- Q64719922 description "ensayu clínicu" @default.
- Q64719922 description "klinisch onderzoek" @default.
- Q64719922 description "клінічне випробування" @default.
- Q64719922 name "Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension." @default.
- Q64719922 type Item @default.
- Q64719922 label "Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension." @default.
- Q64719922 prefLabel "Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension." @default.
- Q64719922 P1050 Q64719922-1E0B5606-4687-4166-AB29-21A909D2B6B9 @default.
- Q64719922 P1050 Q64719922-977D2595-CDD0-44DF-AE5A-941870872533 @default.
- Q64719922 P1132 Q64719922-13C41F0B-E341-46D2-B1BA-519E7A584ABD @default.
- Q64719922 P1476 Q64719922-B83BA2C5-C8D1-4992-880A-B4F6AE68E3BF @default.
- Q64719922 P17 Q64719922-42C5EF39-BE5A-4C3D-A341-9E7C8CA556FB @default.
- Q64719922 P17 Q64719922-BFE15979-3C46-4C53-9E7E-4DBFD9D79FF3 @default.
- Q64719922 P17 Q64719922-C10C8F4F-E62C-468B-9F3A-B354E8952BF5 @default.
- Q64719922 P2899 Q64719922-088A4DA9-A3F0-4CB8-8CCA-32C7BA4F7A8F @default.
- Q64719922 P3098 Q64719922-E515BA2E-75F3-47B6-B933-80863A5109AC @default.
- Q64719922 P31 Q64719922-9DD4AF39-9242-4C2F-928D-A1157ABB65D1 @default.
- Q64719922 P580 Q64719922-6E6160F8-1F30-4CE9-968A-35EBCC8160D3 @default.
- Q64719922 P582 Q64719922-74EED812-89A2-4AEF-B988-9160678729CC @default.
- Q64719922 P6099 Q64719922-70075D5E-57BB-4979-A534-E2D844389AFF @default.
- Q64719922 P8363 Q64719922-D6C5C51E-8097-4880-8B0F-EADFA78C3BC0 @default.
- Q64719922 P1050 Q41861 @default.
- Q64719922 P1050 Q988405 @default.
- Q64719922 P1132 "+328" @default.
- Q64719922 P1476 "A 10 Week, Randomized, Double-blind, Parallel Group, Multi-center Study to Evaluate the Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg qd) to Twice Daily Dosing of Aliskiren (150 mg Bid) in Patients With Essential Hypertension." @default.
- Q64719922 P17 Q183 @default.
- Q64719922 P17 Q29 @default.
- Q64719922 P17 Q30 @default.
- Q64719922 P2899 "+18" @default.
- Q64719922 P3098 "NCT00654875" @default.
- Q64719922 P31 Q30612 @default.
- Q64719922 P580 "2008-03-01T00:00:00Z" @default.
- Q64719922 P582 "2008-11-01T00:00:00Z" @default.
- Q64719922 P6099 Q42825046 @default.
- Q64719922 P8363 Q78089383 @default.